Xmet-SR Tablet is prescribed for the treatment of type 2 diabetes mellitus.
Xmet-SR Tablet Composition :-
Xmet-SR tablet contains :
Metformin Hydrochloride ......... 500mg
( Sustained release )
Metformin hydrochloride is an antidiabetic medicine belonging to a class of drugs called biguanide.
Xmet-SR Tablet Uses :-
Xmet-SR Tablet is used in the treatment of type 2 diabetes mellitus. Xmet-SR Tablet helps to control blood sugar level and prevents serious complications of diabetes.
By lowering or controlling blood sugar levels in this way, you can reduce your risk of serious complications of diabetes such as kidney damage, nerve problems, eye damage and loss of organs.
When Xmet-SR Tablet is used along with a healthy diet and exercise, it helps a lot in controlling blood sugar.
Xmet-SR Tablet Dosage :-
Xmet-SR Tablet is a prescription medicine. Take Xmet-SR Tablet as directed by your doctor. Use Xmet-SR Tablet exactly as directed by the doctor. Do not take a higher or lower dose than directed by your doctor.
Xmet-SR Tablet should be taken during or after a meal. Never self-medicate or change the dosage without a doctor's advice. Do not take 2 or more doses at the same time.
Always try to take Xmet-SR Tablet on regular schedule. Always take the tablet even if you feel well or your blood sugar level is under control. Do not stop taking without your doctor's advice. Otherwise, your blood sugar level may rise again. Do not stop taking Xmet-SR Tablet without asking your doctor. Because the treatment of diabetes is lifelong.
How Does Xmet-SR Tablet Work :-
Xmet-SR tablet contains : Metformin hydrochloride
Metformin hydrochloride :
Metformin hydrochloride is an antidiabetic drugs belonging to a class of drugs called biguanides.
Metformin delays the absorption of glucose from the intestines, by reducing the production of glucose in the liver. And thus metformin works by increasing the sensitivity of the body to insulin.
Thus Xmet-SR tablet works by controlling the level of sugar in the blood.
Xmet-SR Tablet Sideeffects :-
Like all medicines, Xmet-SR Tablet can cause side effects, however not everyone may experience these side effects.
Some common side effects like :
Low blood sugar (hypoglycemia),
Nausea,
Vomiting,
Change in taste,
Diarrhea,
Stomach ache,
Stomach enlargement,
Loss of appetite and many other side effects can occur.
Xmet-SR Tablet Price :-
MRP ₹ : 30.03 ( 15 tabs )
Packing Information :-
Xmet-SR tablet is available in pack of 15 tablets.
Xmet-SR Tablet Marketed By :-
Glenmark Pharmaceuticals Ltd
Xmet-SR Tablet Self life :-
Please see the Expiry date/Manufacture date printed on Xmet-SR tablet pack.
Safety Advice :-
Pregnancy : Safe
Xmet-SR Tablet is safe to use during pregnancy. Animal studies have shown no or no adverse effects on the developing baby.
Breastfeeding : Safe
Xmet-SR Tablet is safe to use during breastfeeding. Limited human data suggests that metformin does not represent any risk to the baby.
Driving : Caution
Your ability to drive may be affected if your blood sugar is too high or low during treatment with Xmet-SR Tablet. Do not drive if you have these symptoms.
Kidney : Caution
Xmet-SR Tablet should be used with caution in patients with kidney disease. Dose adjustment of Xmet-SR Tablet may be needed. Consult your doctor for this. Use of Xmet-SR Tablet is generally not advised in patients with severe kidney disease. Regular monitoring of kidney function tests is advised while you are taking Xmet-SR Tablet.
Liver : Caution
Xmet-SR Tablet should be used with caution in patients with liver disease. Dose adjustment of Xmet-SR Tablet may be needed. Consult your doctor for this. Low dose of Xmet-SR Tablet is generally started in patients with mild liver disease and use of Xmet-SR Tablet is not recommended in patients with severe liver disease.
Alcohol : Unsafe
It is unsafe to consume alcohol while taking Xmet-SR Tablet. Therefore, do not consume alcohol after taking Xmet-SR Tablet.
Classification :-
Drug Name - Metformin Hydrochloride
Therapeutic Class - Antidiabetic drugs, biguanides.
Schedule - Schedule G
Information on this page was last updated on 29 September 2021